Enhancing alloantibody effective during sensitization but not effector phase of skin graft rejection.
D000818:Animals; D000918:Antibody Specificity; D003602:Cytotoxicity, Immunologic; D006084:Graft Rejection; D006085:Graft Survival; D007106:Immune Sera / Q000008:administration & dosage; D007116:Immunization, Passive; D007518:Isoantibodies / Q000276:immunology*; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D008810:Mice, Inbred C57BL; D008811:Mice, Inbred DBA; D016038:Skin Transplantation; D013601:T-Lymphocytes / Q000276:immunology; D013997:Time Factors; D014184:Transplantation, Homologous
D007106:Immune Sera; D007518:Isoantibodies